ArticleProceedings of the National Academy of Sciences of the United States of America2021

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.

Alina Tscherne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.